GlassScriptPhysician profile
Peter H Ashjian
NPI 1801979620
$4,718.11
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,922 · 2020: $24.09 · 2021: $394 · 2022: $214 · 2023: $154 · 2024: $1,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654 · Travel and Lodging: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.00 |
| Travel and Lodging | $510.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,280.40 | 2019-2022 | |
| Axogen | $896.67 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Mentor Worldwide LLC | $265.90 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $110.49 | 2023-2024 | Natrelle Saline-Filled Breast Implants |
| Vioptix INC | $49.17 | 2019-2024 | T. Ox Tissue Oximeter |
| Integra Lifesciences Corporation | $48.47 | 2023 | Durasorb Monofilament Mesh |
| Smith+Nephew, INC. | $25.62 | 2024 | Oasis, Grafix, Grafix Pl |
| Galderma Laboratories, L.P. | $25.01 | 2019 | |
| Tei Biosciences INC | $16.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ashjian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.